Column GROUP Ii, L.P., 10% Owner at RAPT Therapeutics, Inc. (RAPT), bought 1,900 shares at $12.45 ($24K) on 2022-05-25, disclosed to the SEC on 2022-05-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.45 | 63 | $784 | 3.3% |
| 2 | $12.45 | 1,837 | $23K | 96.7% |
| Total | $12.45 avg | 1,900 | $24K | 100% |
| Filing → |
| NGM | BUY | 2019-10-21 | $1.4M | — | Filing → |
| NGM | BUY | 2019-08-09 | $3.1M | — | Filing → |
| NGM | BUY | 2019-05-13 | $496K | — | Filing → |